Subscribe
Search
Close this search box.
Subscribe
Search
Close this search box.

  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center

Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies. Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland

New initiative to promote transition to Organ-on-Chip technology

In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by Dutch startup Bi/ond. The initiative aims to increase awareness and adoption of Organ-on-Chip technology, to improve in vitro research models and reduce animal testing.

TheSocialMedwork: equal access to medicines for everyone, everywhere

We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world access to medication that has not yet been approved in their home countries. We spoke with Vink about his personal motivations for founding TheSocialMedwork and his dream for universal basic healthcare.

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement on Caelus’ microbiome-based food supplements

PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further develop and ultimately commercialize food supplements based on specific microbiota for the purpose of early intervention and nutritional management of diabetes and certain liver disorders.

  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center

Dutch biotech company developing first-in-class T-cell Receptor (TCR) T-cell therapies. Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland

New initiative to promote transition to Organ-on-Chip technology

In an effort to raise awareness for alternatives to animal models, BioVox is helping to promote an Organ-on-Chip initiative by Dutch startup Bi/ond. The initiative aims to increase awareness and adoption of Organ-on-Chip technology, to improve in vitro research models and reduce animal testing.

TheSocialMedwork: equal access to medicines for everyone, everywhere

We recently sat down with Sjaak Vink, the visionary entrepreneur behind TheSocialMedwork. This enterprise gives patients all over the world access to medication that has not yet been approved in their home countries. We spoke with Vink about his personal motivations for founding TheSocialMedwork and his dream for universal basic healthcare.

Caelus Health and Nestlé Health Science sign exclusive global development & option agreement on Caelus’ microbiome-based food supplements

PRESS RELEASE Amsterdam/Beerse, November 25, 2019 – Caelus Health, which develops food supplements and pharmaceutical products for the prevention, early treatment and management of cardio-metabolic diseases, is entering into a strategic collaboration with Nestlé Health Science (NHSc). The aim is to further develop and ultimately commercialize food supplements based on specific microbiota for the purpose of early intervention and nutritional management of diabetes and certain liver disorders.